CAR T-cell Therapy: Your Questions Answered
Update: 2025-05-10
Description
<figure class="wp-caption alignright" style="width: 250px;">
<figcaption class="wp-caption-text">
CLICK HERE to participate in our episode survey.
<figcaption class="wp-caption-text">Trent Wang, MD
</figcaption></figure>Curious about CAR T-cell therapy? We went straight to the source for answers.
In this episode, the LLS Patient Education team visited The University of Miami Sylvester Cancer Center to meet with Dr. Trent Wang. He answered some of the most frequently asked questions from our patients and caregivers about this innovative cancer treatment – from who’s eligible and what to expect, to side effects, caregiver roles, and exciting future developments.
CLICK HERE to participate in our episode survey.
Mentioned on this episode:
- CAR T-cell therapy
- Stem cell transplantation
- Graft-vs-host disease (GVHD)
- LLS Clinical Trial Support Center
- Bispecific antibodies – Immunotherapy fact sheet
Additional LLS Support Resources:
- Free Nutrition Consultations
- Information Specialists
- Financial support
- Free telephone/web patient programs
- Free booklets
- Young Adult Resources
- Online chats
- Support groups
- Caregiver support
- Caregiver Workbook
- Advocacy and Public Policy
- Survivorship Workbook
- LLS Community
- Mental Health Resources
Supported by Bristol Myers Squibb; Johnson & Johnson & Legend Biotech; and Kite, a Gilead Company.
The post CAR T-cell Therapy: Your Questions Answered first appeared on The Bloodline with Blood Cancer United Podcast.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
